Dual-Agonist Appetite and Glucose Control Tirzepatide at Magnolia Functional Wellness uses dual-agonist injectable therapy to support appetite control, glucose regulation, and weight loss
Common Early Side Effects and Management Strategies Nausea ranks as the most bothersome early side effect, but it responds well to dietary modifications including smaller meal portions, increased hydration, ginger supplementation, and avoiding high-fat or spicy foods
Once inflammation subsides, re-epithelialization begins, typically around 23 days after injury, as fibroblasts infiltrate the wound site, initiating collagen and extracellular matrix (ECM) deposition to create a scaffold for tissue repair
When stored at -20C, please use it within 6 months.
Weight loss conversations often revolve around calories, exercise routines, and hormones such as insulin or GLP-1
References Chung JH, Heo S (2024) Varicose veins and the diagnosis of chronic venous disease in the lower extremities
